Biocryst Pharmaceuticals reported $-64284000 in Pre-Tax Profit for its first fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Pre Tax Profit Change
Alexion Pharmaceuticals ALXN:US $ 940.1M 164.6M
Alnylam Pharmaceuticals ALNY:US $ -188.33M 10.94M
Chemocentryx CCXI:US $ -39.21M 9.5M
Chugai Pharma 4519:JP Y 97016M 32776M
Daiichi Sankyo 4568:JP Y 47062M 72506M
Enanta Pharmaceuticals ENTA:US $ -33.41M 4.25M
GlaxoSmithKline GSK:LN 1482M 225M
IONIS PHARMACEUT IONS:US $ -81M 8.74M
Karyopharm Therapeutics KPTI:US $ -53448000 3.82M
Neurocrine Biosciences NBIX:US $ 57.5M 30.3M
Novavax NVAX:US $ -348.77M 129.07M
Ptc Therapeutics PTCT:US $ -117.88M 10.31M
Regeneron Pharmaceuticals REGN:US $ 3898.3M 2658.7M
Sarepta Therapeutics SRPT:US $ -81.76M 85.63M
Ultragenyx Pharmaceutical RARE:US $ -121.96M 13.8M
YTE INCY:US $ 199.6M 31.06M
Zogenix ZGNX:US $ -58.9M 3.27M